Clive Albert, MD
Gastroenterology · Cumming, GANPI 1821099987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 38.6% of the total.
Across 340 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$783
- Regeneron Healthcare Solutions, Inc.$707
- Pfizer$563
- Gilead$466
- Madrigal Pharmaceuticals$436
- plus $4K from 29 others
Across 4 payments — averaging $4850.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$19K
What the payments were for
- Consulting fees$470%
- Speaking & faculty fees$4004%
- Food & beverage$9,98994%
- Education$1371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $4,077 |
| Johnson & Johnson(2 entities) | 24 | $783 |
| Regeneron Healthcare Solutions, Inc. | 27 | $707 |
| Pfizer | 18 | $563 |
| Gilead | 5 | $466 |
| Madrigal Pharmaceuticals | 6 | $436 |
| Ardelyx, Inc. | 14 | $434 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $252 |
| Janssen Scientific Affairs, LLC | 2 | $229 |
| Lilly USA, LLC | 10 | $220 |
| Portola Pharmaceuticals, LLC | 3 | $219 |
| Medtronic | 3 | $193 |
| Sanofi | 3 | $169 |
| QOL Medical, LLC | 7 | $167 |
| Ipsen Biopharmaceuticals, Inc | 4 | $144 |
| Phathom Pharmaceuticals, Inc. | 3 | $141 |
| Ferring Pharmaceuticals Inc. | 5 | $104 |
| E.r. Squibb & Sons, L.L.C. | 1 | $102 |
| Novo Nordisk | 1 | $96 |
| Bristol Myers Squibb | 6 | $93 |
| Aimmune Therapeutics, Inc. | 1 | $87 |
| Merck | 4 | $80 |
| Daiichi Sankyo Inc. | 4 | $77 |
| Shionogi Inc | 2 | $70 |
| Covidien LP | 1 | $67 |
| Intercept Pharmaceuticals, Inc. | 3 | $63 |
| Braintree Laboratories, Inc. | 3 | $54 |
| Boehringer Ingelheim | 2 | $36 |
| Evoke Pharma, Inc. | 2 | $32 |
| UCB, Inc. | 2 | $30 |
| Shire North American Group Inc | 1 | $25 |
| Redhill Biopharma Inc. | 1 | $17 |
| Orphalan Inc | 1 | $16 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,573 in reported general payments places this provider in the 80th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $84,652 |
| Pantoprazole Sodium | 182 | $2,615 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 71 | $1,465 |
| Colestipol Hcl | 12 | $1,368 |
| CholestyramineCholestyramine (With Sugar) | 12 | $1,037 |
| Omeprazole | 66 | $712 |
| Famotidine | 25 | $297 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cumming
- Simon CofrancescoCumming$16K
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Satish RaoAugusta$335K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Aja McCutchenWinder$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.